1. Change in Vitamin D Levels and Risk of Severe Vitamin D Deficiency over 48 Weeks among HIV-1-Infected, Treatment-Naive Adults Receiving Rilpivirine or Efavirenz in a Phase III Trial (Echo). Issue 2 (February 2014) Authors: Wohl, David A; Orkin, Chloe; Doroana, Manuela; Pilotto, José H; Sungkanuparph, Somnuek; Yeni, Patrick; Vanveggel, Simon; Deckx, Henri; Boven, Katia Journal: Antiviral therapy Issue: Volume 19:Issue 2(2014) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI. Issue 3 (4th May 2017) Authors: Arribas, Jose R.; DeJesus, Edwin; van Lunzen, Jan; Zurawski, Christine; Doroana, Manuela; Towner, William; Lazzarin, Adriano; Nelson, Mark; McColl, Damian; Andreatta, Kristen; Swamy, Raji; Szwarcberg, Javier; Nguyen, Thai Journal: HIV clinical trials Issue: Volume 18:Issue 3(2017) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme. Issue 6 (December 2015) Authors: Gori, Andrea; Doroana, Manuela; Chernova, Oksana; Rockstroh, Jürgen K.; Banhegyi, Denes; Bergin, Colm; Verucchi, Gabriella; Liu, Chris; DeMasi, Ralph; Hadacek, Blanca; Nelson, Mark Journal: Journal of infection Issue: Volume 71:Issue 6(2015) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗